Sloning and Research & Innovation Japan Announce Distribution Partnership
News Jul 20, 2007
Sloning Biotechnology has announced a distribution partnership with Research & Innovation Japan Inc. (RIJ).
RIJ will exclusively market and sell Sloning´s gene synthesis service (Slonomics™) and the product family of gene mutant libraries (Slonomax™) in Japan.
“We are very pleased that RIJ will join our global network of qualified distributors. Their technological strength and market awareness makes RIJ the ideal partner to co-develop the Japanese market.” stated Thomas Matthes, the company CBO.
Kiyohiko Hirasawa, founder and CEO of RIJ said “Sloning´s products and services perfectly addressing the current demand in genomics research and protein engineering. We are looking forward to represent Sloning in Japan”.
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE